Severity assessment of single-dose Oxford-AstraZeneca vaccinated individuals infected with severe acute respiratory syndrome coronavirus 2 in Southeast Bangladesh
Background and Aim: A vaccine program for coronavirus illness (coronavirus disease [COVID-19]) is currently underway in numerous regions of the world, including Bangladesh, but no health data on those who have been vaccinated are available at this time. The study aimed to investigate the health cond...
Guardado en:
Autores principales: | Eaftekhar Ahmed Rana, Pronesh Dutta, Md. Sirazul Islam, Tanvir Ahmad Nizami, Tridip Das, Sharmin Chowdhury, Goutam Buddha Das |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Veterinary World
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca0f020b2d7e4993a301b4ae208b5348 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Waleed H. Mahallawi, et al.
Publicado: (2021) -
Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
por: Ava Soltani Hekmat, et al.
Publicado: (2021) -
New Tendencies in the Development of the EU Competition Law – the AstraZeneca case
por: K. V. Entin
Publicado: (2011) -
Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly Recipient
por: Joel Ern Zher Chan, et al.
Publicado: (2021) -
Oxford today
Publicado: (1988)